Globeflex Capital’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Hold
4,496
0.02% 355
2026
Q1
$128K Hold
4,496
0.02% 352
2025
Q4
$178K Buy
4,496
+40
+0.9% +$1.47K 0.03% 311
2025
Q3
$157K Buy
+4,456
New +$154K 0.02% 326
2017
Q1
Sell
-47,700
Closed -$933K 466
2016
Q4
$933K Buy
+47,700
New +$865K 0.23% 172
2014
Q3
Sell
-50
Closed 566
2014
Q2
$0 Sell
50
-10
-17% -$166 ﹤0.01% 603
2014
Q1
$1K Buy
+60
New +$1.23K ﹤0.01% 496

Other funds holding ATRC

Globeflex Capital's ATRC Position: Q2 2026 in Review

Globeflex Capital held its AtriCure (ATRC) position steady in Q2 2026 at 4,496 shares worth $126K. The position accounts for 0.02% of the portfolio, ranked #355.

Globeflex Capital first reported a position in ATRC in Q1 2014 and has held it in 7 quarters since. The position peaked at $933K in Q4 2016. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Globeflex Capital held 4,496 shares of AtriCure worth $126K as of Q2 2026.
  • Globeflex Capital left its AtriCure share count unchanged in Q2 2026.
  • AtriCure made up 0.02% of Globeflex Capital's portfolio in Q2 2026, its #355 holding.
  • Globeflex Capital first reported a position in AtriCure in Q1 2014 and has held it in 7 quarters since.
  • Globeflex Capital's AtriCure position peaked at $933K in Q4 2016.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.